Evaro

Series A · $25M · October 2026 · Europe

What it sells

Prescription healthcare that partners embed in their own platforms: online consultations, clinician prescribing, licensed pharmacy, delivery and aftercare across 500+ treatments.

Business model breakdown

Buyer: who owns the budget?

Business leaders at consumer brands, healthcare companies and startups.

Distribution: how it reaches customers

Book a call / become a partner; white-label and bespoke integration, self-service portal coming soon.

Funding history and coverage

Round dateStageAmountInvestorsSource
2026-10-13Series A$25M—thesaasnews.com

Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-17.